Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Total Liabilities (2020 - 2024)

Immuneering (IMRX) has 5 years of Total Liabilities data on record, last reported at $10.8 million in Q3 2024.

  • For Q3 2024, Total Liabilities rose 9.86% year-over-year to $10.8 million; the TTM value through Sep 2024 reached $10.8 million, up 9.86%, while the annual FY2023 figure was $12.0 million, 4.06% down from the prior year.
  • Total Liabilities reached $10.8 million in Q3 2024 per IMRX's latest filing, up from $10.8 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $28.5 million in Q1 2021 and bottomed at $2.8 million in Q4 2020.
  • Average Total Liabilities over 5 years is $10.9 million, with a median of $10.3 million recorded in 2021.
  • Peak YoY movement for Total Liabilities: skyrocketed 282.94% in 2021, then plummeted 70.59% in 2022.
  • A 5-year view of Total Liabilities shows it stood at $2.8 million in 2020, then surged by 282.94% to $10.7 million in 2021, then increased by 16.71% to $12.5 million in 2022, then decreased by 4.06% to $12.0 million in 2023, then fell by 9.76% to $10.8 million in 2024.
  • Per Business Quant database, its latest 3 readings for Total Liabilities were $10.8 million in Q3 2024, $10.8 million in Q2 2024, and $9.3 million in Q1 2024.